A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by McMaster University
Sponsor:
Collaborators:
GlaxoSmithKline
Hamilton Health Sciences Corporation
Novartis
Information provided by (Responsible Party):
Donald Arnold, McMaster University
ClinicalTrials.gov Identifier:
NCT01621204
First received: June 12, 2012
Last updated: March 15, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)